Evidence actions
Exact observation fact_1dzwp37
What is GILEAD SCIENCES, INC. doing now, what supports the move, and where does the evidence end? Start with price, then add history and method.
GILD is higher by +0.42% at 146.74 USD.
52-week range: 108.46 to 157.29.
GILEAD SCIENCES, INC. is covered as a listed equity. Price, chart, seasonality, attributed news, comparable assets, and research actions remain in scope. Company-only datasets stay off when they do not describe this instrument.
The current CBOE coverage set does not include this instrument.
The issuer does not have a mapped company identifier in the current fundamentals set.
Listed equity or fund distributions are included when the upstream record is available.
SEC filings, ownership context, and applicable public disclosures share one chapter.
Published company earnings dates can appear on the chart when present.
Exact observation fact_1dzwp37
Exact observation fact_1oee0rh
Exact observation fact_11mfhu1
Exact observation fact_06rxmdz
Exact observation fact_0ls3069
No recent wires mention this symbol.
The desk checks delayed market quotes every 30 seconds through . The quote payload separates upstream observation time from edge retrieval time. The chart and the 52-week range read from Yahoo's chart endpoint; the news rail reads Yahoo's search/news endpoint filtered to the last 24 hours.
Every number on this page carries a hover tooltip. No cookies, no signup walls. The page is one HTML file plus a few client-side fetches.
Data is informational; not investment advice.